003229.
106. Ibegbuna V, Nicolaides AN, Sowade O, Leon M, Geroulakos G.
Venous elasticity after treatment with Daﬂon 500 mg. Angiology
1997;48:45-9.
107. Krzysciak W, Cierniak A, Kozka M, Koziel J. Oxidative DNA damage
in blood of CVD patients taking detralex. Open Cardiovasc Med J
2011;5:179-87.
108. Pietrzycka A, Kozka M, Urbanek T, Stpniewski M, Kucharzewski M.
Effect of micronized puriﬁed ﬂavonoid fraction therapy on endothelin-1 and TNF-alpha levels in relation to antioxidant enzyme
balance in the peripheral blood of women with varicose veins. Curr
Vasc Pharmacol 2015;13:801-8.
109. Shoab SS, Porter J, Scurr JH, Coleridge-Smith PD. Endothelial activation response to oral micronised ﬂavonoid therapy in patients
with chronic venous disease–a prospective study. Eur J Vasc Endovasc Surg 1999;17:313-8.
110. Tsukanov YT, Nikolaichuk AI. Orthostatic-loading-induced transient
venous reﬂuxes (day orthostatic loading test), and remedial effect of
micronized puriﬁed ﬂavonoid fraction in patients with telangiectasia and reticular vein. Int Angiol 2017;36:189-96.
111. Jantet G. Chronic venous insufﬁciency: worldwide results of the
RELIEF study. Reﬂux assEssment and quaLity of lIfe improvEment
with micronized Flavonoids. Angiology 2000;51(1):31-7.
112. Allaert FA. Meta-analysis of the impact of the principal venoactive
drugs agents on malleolar venous edema. Int Angiol 2012